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Abstract 
Immobility time of rats in the forced swim test was reduced after bilateral infusion of an 18-mer antisense phosphorothioate 
oligodeoxynucleotide targeted to the glucocorticoid receptor mRNA into the dentate gyms of the hippocampus. Vehicle-, sense- and 
scrambled sequence-treated animals spent significantly more time immobile than antisense-treated animals during the initial test. 
Immunolabeling of the glucocorticoid receptor in brain sections demonstrated a reduced expression of glucocorticoid receptor proteins in 
antisense-treated dentate gyms compared to the contralateral sense-treated dentate gyms or contralateral scrambled sequence-treated 
dentate gyms. During the initial test the time spent on immobility was also reduced when rats were treated with the glucocorticoid 
receptor antagonist RU38486 (17/3-hydroxy- 1113-(4-dimethylamino-phenyl)17a-(1-propynyl)estra-4,9-diene-3-one)) 6 h (but not 1 h) 
earlier. These results demonstrate he participation of glucocorticoid receptors in the expression of immobility in a forced swim test 
during the initial test. 
Keywords: Immobility behaviour: Forced swim test; Antisense; S-Oligodeoxynucleotide; Glucocorticoid receptor; RU38486; Central nervous ystem 
1. Introduction 
Corticosteroids from the adrenal cortex influence a 
variety of behaviours (e.g., De Kloet, 1991). These hor- 
mones act via two intracellular eceptor systems, i.e., the 
mineralocorticoid receptor and the glucocorticoid receptor 
(Reul and De Kloet, 1985). The two receptor types differ 
in their neuroanatomical distribution, their affinity for 
corticosterone, their regulation and their function (for re- 
view, De Kloet, 1991). Both mineralocorticoid receptors 
and glucocorticoid receptors appear in high concentrations 
in the hippocampal formation (Fuxe et al., 1985; Reul and 
De Kloet, 1985; Van Eekelen et al., 1987). Low circulating 
levels of corticosterone predominantly occupy mineralo- 
corticoid receptors, whereas after stress and during the 
circadian peak both mineralocorticoid receptors and gluco- 
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corticoid receptors are activated (Reul et al., 1987). Be- 
havioural effects of the synthetic glucocorticoid receptor 
antagonist and the mineralocorticoid receptor antagonist 
have been measured in animal models designed to examine 
anxiety (Korte et al., 1995), learning and memory (De 
Kloet et al., 1988; Jefferys et al., 1983; Jefferys and 
Funder, 1987; Oitzl and De Kloet, 1992; Oitzl et al., 1994) 
and learned helplessness (Papolos et ai., 1993). One of the 
behaviours ensitive to corticosterone (the principle gluco- 
corticoid in the rat) is immobility in the Porsolt forced 
swim test. When rats are forced to swim in a confined 
space from which they cannot escape they will, after an 
initial period of vigorous activity, stay afloat in a charac- 
teristic immobile position. Acquisition of this immobility 
is usually measured uring an initial 15-min test period. 
When subjected 24 h later to a 5-min retest, the rats spend 
most of the time immobile. Jefferys and colleagues (Jef- 
ferys et al., 1983; Jefferys and Funder, 1987) were the first 
to show that the presence of glucocorticoids and opioid 
peptides after the initial test is necessary for the retention 
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of the acquired immobility response in the retest. This 
finding was confirmed by De Kloet et al. (1988) who have 
shown that local administration of the glucocorticoid re- 
ceptor antagonist, RU38486, into the dentate gyrus of the 
hippocampus directly after the initial test disrupted this 
retention. Recently, however, it has been shown that inhi- 
bition of the synthesis of corticosterone with metyrapone 
reduced the immobility time during both initial test and 
retest (Bfiez and Volosin, 1994). 
The aim of the present investigation was to assess the 
potential glucocorticoid receptor participation in the ex- 
pression of behavioural immobility in the forced swim test 
using a new approach to influence glucocorticoid receptor 
function. Antisense to the glucocorticoid receptor mRNA 
was administered locally into the dentate gyrus to prevent 
translation. It is assumed that antisense oligodeoxynu- 
cleotides to specific mRNAs block the translation and 
thereby the synthesis of proteins (Wahlestedt et al., 1993). 
2. Materials and methods 
2.1. Animals 
Male Wistar rats, weighing 300-400 g at the start of the 
experiment, were used. They were housed 6 per cage. 
After surgery the rats were housed individually and were 
allowed 10 days for recovery. Housing conditions were a 
constant temperature of 2 I°C on a 12-h light-dark regimen 
(light on between 08:00-20:00 h) with free access to 
standard rat chow and tap water. 
2.2. Procedure 
As demonstrated earlier, specific inhibition of neuro- 
transmitter receptor expression in the living brain can be 
accomplished by the use of antisense oligodeoxynu- 
cleotides (Wahlestedt et al., 1993). For local administration 
of the antisense oligodeoxynucleotide to glucocorticoid 
receptor mRNA, scrambled sequence, sense or vehicle, 
cannulae were placed (under ether anaesthesia) bilaterally 
into the dentate gyrus of the hippocampus; AP = -3 .6  
mm from the bregma; L = + 1.4; DV = -3 .3  from the 
dura mater (according to the Paxinos stereotaxic rat brain 
map). Antisense (5'-GGA-TTC-TTT-GGA-GTC-CAT-3') 
was targeted at the codons immediately downstream of the 
initiation codon (Miesfeld et al., 1986). All oligodeoxynu- 
cleotides were phosphorothioated in all positions, except 
the 3' and 5' base positions. A scrambled sequence of the 
antisense oligodeoxynucleotide (5'-AAT-GCT-CGC-TTG- 
ATG-TTG-3'), sense oligodeoxynucleotide (5'-ATG-GAC- 
TCC-AAA-GAA-TCC-3') and vehicle (distilled water) 
were used as controls. The antisense, the scrambled se- 
quence and the sense (2 nmol) or vehicle were bilaterally 
infused through injectors (0.29 mm o.d.) in a volume of 1 
/xl/side into the dentate gyrus over a period of 7.5 min; 1 
additional min delay was allowed before the injectors were 
retracted. The possible consequence of inhibition of ge- 
netic glucocorticoid receptor expression on immobility be- 
haviour in the forced swim test and retest was studied 6 
and 30 h later, respectively. The synthetic glucocorticoid 
receptor antagonist RU38486 (Gaillard et al., 1984; Mogu- 
ilewski and Philibert, 1984) (17/3-hydroxy- 11/3-(4-di- 
methylamino-phenyl) 17~-( 1 -propynyl)estra-4,9-diene-3- 
one) (2.5 mg/100 g body weight), was freshly prepared 
before the experiment by dissolving the crystalline steroid 
in polyethylene glycol for subcutaneous ( .c.) administra- 
tion 6 h and 1 h before the initial forced swim test. Control 
animals received the vehicle (polyethylene glycol) only. 
The following day, 24 h after the initial test, time spent 
immobile was measured uring a 5-min retest period. 
The rats were placed in a narrow Plexiglas cylinder 
(height 50 cm, diameter 19 cm), containing 23-cm-deep 
water for 15 rain (initial test, behaviour was scored in 3 
periods of 5 rain), followed by a 5-min retest 24 h later. 
The temperature of the water, i.e, 25°C, has proved to be 
essential to detect glucocorticoid effects (Peeters et al., 
1992). Fresh water was used for each animal (Abel, 1993). 
Typically, rats paddle vigorously when first immersed, 
then become relatively immobile and adopt a characteristic 
vertical floating response (Abel, 1993, 1994; Porsolt et al., 
1977). The duration of absence of hindleg movement was 
recorded as a measure of immobility. The rats were dried 
after they had swum. All tests were performed between 
16:00-19:00 h. After the experiments, localization of the 
tip of the injectors was verified in cryostat brain sections. 
Four animals had cannula misplacement and were ex- 
cluded. 
2.3. lmmunocytochemistry 
The expression of glucocorticoid receptors was studied 
immunocytochemically in 8 animals which were infused 
with glucocorticoid receptor antisense in the left dentate 
gyrus, and with sense in the contralateral dentate gyrus as 
described above and in another group of 7 animals, with 
glucocorticoid receptor antisense in the left dentate gyrus, 
and with scrambled sequence in the contralateral dentate 
gyrus. Six hours later the rats were perfused transcardially 
under deep pentobarbital anaesthesia with heparinized 
saline followed by 4% paraformaldehyde in 0.1 M phos- 
phate buffer (PB, pH = 7.4). The intracellular localization 
of glucocorticoid receptor was studied by means of a 
polyclonal (Rabbit) anti-human glucocorticoid receptor an- 
tibody (GR57; Affinity Bioreagents) as described earlier 
(McGimsey et al., 1991). Briefly, brain sections of 40 /xm 
were cut on a cryostat microtome and incubated in primary 
antibody (1 : 100) in phosphate-buffered saline (PBS; 0.01 
M, pH 7.4), containing 2% normal goat serum for 72 h at 
4°C. After rinsing, the sections were incubated with sec- 
ondary antibody (biotinylated goat anti-rabbit immuno- 
globulin G, 1 : 200) for 2 h, followed by a 2 h exposure to 
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Fig. 1. Immobility behaviour (mean ±S.E.M.; n = 8-10) in the forced 
swim test during the first day (T = 5, 10, and 15 min) and during retest 
(T = 5 min), 6 h and 30 h following bilateral intra-dentate gyrus infusion 
of vehicle (©), a control oligodeoxynucleotide ('sense'; v) ,  an 18-mer 
phosphorothioate oligodeoxynucleotide complementary to the glucocorti- 
coid receptor mRNA ('antisense'; a )  or a scrambled sequence ('scram- 
bled'; • ). 
horseradish-peroxidase-streptavidin (1:200). Finally, the 
tissue-bound peroxidase was visualized with diaminobenzi- 
dine (50 mg/100 ml PBS) and 0.01% H202. Between 
incubations the sections were rinsed several times in PBS 
over 1 h. 
The density of glucocorticoid receptor immunolabeling 
in the nuclear compartment of the granular cell layer in the 
dentate gyrus and the pyramidal CA1 cell layer was deter- 
mined by measuring the optical density using an image- 
analysing system (Zeiss, IBAS). The optical density was 
expressed in arbitrary units corresponding to grey levels. 
2.4. Statistics 
Durations of immobility were tested for overall treat- 
ment effect using the Kruskal-Wallis analysis of variance 
(ANOVA), while individual comparisons were tested using 
the Mann-Whitney test. The optical density of glucocorti- 
coid receptor immunolabeling in the antisense-treated site 
was compared with the sense-treated or scrambled se- 
I 
Fig. 2. Photomicrographs of glucocorticoid receptor immunolabeling of the dentate gyrus 6 h after antisense (left, B) and sense treatment (right, C). A 
decrease of glucocorticoid receptor immunolabeling was mainly observed in the granule cells of the glucocorticoid receptor antisense-treated si e (2 
nmol//xl) compared to the sense-treated contralateral dentate gyrus in hippocampus (bar = 200 /zm; gr = granular cell layer of dentate gyms; hil = hilus) 
and in more detail (B, C; bar = 50 /xm). 
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quence-treated contralateral site in the brain with the aid of 
paired t-tests. A probability level of P < 0.05 was taken as 
significant. 
3. Results 
Fig. 1 shows that high scores for immobility time were 
observed in vehicle-, sense- and scrambled sequence- 
treated animals during exposure to the initial forced swim 
test. The immobility behaviour was reduced in glucocorti- 
coid receptor antisense-treated animals during both test 
and retest. Kruskal-Wallis ANOVA revealed a significant 
overall treatment effect for all periods during test and 
retest; P=0.0002; P<0.0001; P=0.0002 and P= 
0.017, respectively. Antisense-treated animals showed sig- 
nificantly lower immobility levels compared to vehicle- 
and sense-treated animals during the initial test (T 5, both 
P < 0.01; T]0, both P < 0.01 and TIs, P < 0.05, P < 0.01 
respectively) and during the retest (both P < 0.01). Com- 
pared to scrambled sequence-treated animals, antisense- 
treated rats were significantly less immobile during the 
initial test (TI0; P < 0.01), but not in the retest. 
Fig. 2 shows the less intense glucocorticoid receptor 
immunolabeling of the granule cells of the antisense-treated 
dentate gyrus (left) compared to the contralateral sense- 
treated entate gyrus (right) of the same rat. This was also 
the case for the antisense-treated dentate gyrus compared 
to the contralateral scrambled sequence-treated dentate 
gyrus. The optical density of glucocorticoid receptor im- 
munolabeling was significantly decreased in the antisense- 
treated dentate gyrus ( -18 .0  _+ 2.5%) compared to the 
contralateral sense-treated dentate gyrus (P  = 0.0017). The 
optical density of glucocorticoid receptor immunolabeling 
also was significantly decreased in the antisense-treated 
dentate gyrus ( -15.1 _+ 3.2%) compared to the contralat- 
eral scrambled sequence-treated dentate gyrus (P  = 
0.0046). No significant differences in optical density were 
measured in the pyramidal CA1 neurons. 
Fig. 3 (left) shows that if the glucocorticoid receptor 
antagonist was administered 6 h before the initial test, the 
time spent on immobility was significantly reduced uring 
the T 5 and the T~5 periods of the initial test (P = 0.0089 
and P = 0.026, respectively) and during the retest (P = 
0.013). Fig. 3 (right) shows reduced immobility scores for 
the glucocorticoid receptor antagonist-treated (1 h before 
initial test) animals compared to vehicle-treated animals 
(P  = 0.035) during the 5-min retest, without affecting 
immobility scores during the 15-min initial test. 
4. Discussion 
Our results suggest that hippocampal glucocorticoid 
receptors in the dentate gyrus are involved in the display 
of immobility behaviour in the forced swim test. Rats 
spent less time on immobility behaviour in both the initial 
test and the retest after bilateral infusion of antisense 
phosphorothioate oligodeoxynucleotide, targeted to the 
glucocorticoid receptor mRNA, into the dentate gyrus of 
the hippocampus compared to vehicle- and sense-treated 
controls. Compared to the scrambled sequence-treated rats, 
antisense-treated animals showed reduced immobility lev- 
els during the initial test. The decreased ensity of the 
glucocorticoid receptor immunolabeling in the antisense- 
treated entate gyrus compared to that in both the sense- 
treated side and the scrambled sequence-treated si e sug- 
gests that antisense treatment produced a decrease in the 
amount of target glucocorticoid receptor protein translated. 
Blockade of glucocorticoid receptors with RU38486 6 h 
before the initial test reduced immobility during both test 
and retest, whereas the glucocorticoid receptor antagonist 
treatment 1 h before the initial test only reduced the 
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Fig. 3. Immobility behaviour (mean + S.E.M.) in vehicle-treated animals (O) compared to that in systemic RU38486-treated (2.5 mg/100 g; 1 h and 6 h 
prior to initial test) animals (D)  during the forced swim test on the first day (i.e., initial test; T = 5, 10, and 15 min) and during the 5-rain retest 24 h later. 
S.M. Korte et al. / European Journal of Pharmacology 301 (1996) 19- 25 23 
The decreased intensity of the glucocorticoid receptor 
immunolabeling in the antisense-treated d ntate gyrus, with 
no difference in glucocorticoid receptor immunolabeling in 
the CA l, reflects a local decrease in the target glucocorti- 
coid receptor protein. The effect of antisense treatment on 
glucocorticoid receptor immunocytochemistry suggests a 
partially inhibited expression of glucocorticoid receptors in 
the dentate gyrus (minus 15-18%). Furthermore a reduc- 
tion in the display of immobility behaviour in the init ial 
test was seen after treatment with both glucocorticoid 
receptor antisense and gtucocorticoid receptor antagonist 
RU38486 (both given 6 h before testing). Therefore it is 
suggested that glucocorticoid receptors are involved in the 
display of immobility during the initial test. This conclu- 
sion is supported by the recent indirect finding of Bfiez and 
Volosin (1994) who showed that the corticosterone synthe- 
sis inhibitor, metyrapone (given 3 h earlier), also reduced 
immobility, in a comparable way to antisense, during the 
initial forced swim test but also in the retest. Cortico- 
sterone administration reversed this effect in a dose-depen- 
dent fashion. In addition, transgenic mice with glucocorti- 
coid receptor function impaired by partial 'knock out' of 
the genes encoding for glucocorticoid receptor proteins 
show decreased immobility time, in the forced swim test, 
during the initial test and the retest compared to the 
controls (Beaulieu et al., 1994). In contrast o the above- 
mentioned results, we found that 1 h earlier treatment with 
the glucocorticoid receptor antagonist failed to have an 
effect during the initial test. Therefore we postulate that 
the time interval between treatment (by which binding of 
corticosterone to glucocorticoid receptors i disturbed) and 
testing is crucial for the final behavioural outcome. 
There is a large body of literature which describes 
effects of glucocorticoids on the retention of the immobile 
behaviour only during a 5-min retest session, with no 
mention of effects on the initial 15-min test 24 h earlier 
(Jefferys et al., 1983; Jefferys and Funder, 1987; Veldhuis 
et al., 1985; De Kloet et al., 1988; De Kloet, 1991). 
Jefferys et al. (1983) discovered that adrenalectomy im- 
paired retention of the acquired immobility response. The 
effect of adrenalectomy was reversed by dexamethasone 
(microgram dose, subcutaneous) or corticosterone (milli- 
gram dose), given within 1 h after the initial test, but not 
by the mineralocorticoid deoxycorticosterone. Treatment 
of adrenalectomized rats with the glucocorticoid receptor 
antagonist RU38486 prior to dexamethasone administra- 
tion dose dependently blocked the effect of the glucocorti- 
coid (Veldhuis et al., 1985). Jefferys et al. (1983) and 
Jefferys and Funder (1987) postulated that glucocorticoids 
(and an additional component, e.g., opioid peptides) are 
involved in the retention of information post-stress and 
that these hormones act on the central nervous system 
directly rather than via the pituitary, since the response to 
adrenalectomy is not dependent on the presence of the 
pituitary gland. De Kloet et al. (1988) found that 10 ng of 
the glucocorticoid receptor antagonist, RU38486, given 
intracerebroventricularly or 1 ng into the dorsal hippocam- 
pus blocked this retention of acquired immobility. 
In the present study we replicated the finding that the 
glucocorticoid receptor antagonist, RU38486 (1 h before 
initial test, subcutaneous), reduced the time spent on im- 
mobility in the retest, but not in the initial test. Although 
the reduction in immobility was less robust than reported 
earlier (probably due to use of another route of administra- 
tion) (De Kloet et al., 1988), the difference was highly 
significant. One should keep in mind that, following sys- 
temic RU38486 treatment, disinhibition of the pituitary- 
adrenal system occurs which leads to a rise in circulating 
corticosterone (Ratka et al., 1989), These higher cortico- 
sterone levels may interact with the action of the gluco- 
corticoid receptor antagonist in the brain. Furthermore it
must be noted that the immobility scores in the present 
study reached higher values than in the above-mentioned 
studies (Jefferys et al., 1983; De Kloet et al., 1988). This 
may be explained partly by the use of adult rats (+ 350 g) 
in the present study compared to that of younger rats 
(+ 200 g) in the earlier studies. It was reported that the 
duration of immobility behaviour depends on the age of 
the animals (Abel, 1993). Surprisingly we found no differ- 
ence in time spent on immobility between the antisense- 
treated and scrambled sequence-treated animals during the 
retest. This discrepancy might be explained by artifactual 
effects of the scrambled sequence. There was, however, a 
reduction in immobility in the glucocorticoid receptor anti- 
sense-treated animals as compared to vehicle- or sense- 
treated controls in the retest. 
The immobile behaviour in the Porsolt forced swim test 
is often taken as a state of lowered mood in rats, and this 
immobility time is reduced by antidepressants (Porsolt et 
al., 1977). Therefore, one might argue that the antisense 
treatment or glucocorticoid receptor blockade simulates an 
antidepressive-like action. But this alternative xplanation 
is not supported by the finding that antidepressants s imu- 
late glucocorticoid receptor gene expression and the fact 
that the time course of antidepressant actions on gluco- 
corticoid receptors follows that of clinical improvement of
depression (Barden et al., 1995). Alternatively, the immo- 
bile posture can be viewed as an energy-conserving strat- 
egy (Hawkins et al., 1978; West, 1990). According to this 
line of reasoning immobility behaviour is a successful 
passive behavioural strategy. The reduction in immobility 
time during all periods (most prominent during init ial test) 
by the glucocorticoid receptor antisense suggests a shift to 
a behavioural ctivation. It is proposed that the hippocam- 
pus, which contains high concentrations of glucocorticoid 
receptors and mineralocorticoid receptors, is a target of 
actions of corticosteroids and thereby promotes be- 
havioural adaptation (i.e., behavioural immobility). It is 
plausible that glucocorticoid receptor antisense, by reduc- 
ing the number of glucocorticoid receptors in the dorsal 
hippocampus, changes the balance of mineralocorticoid 
receptor and glucocorticoid receptor number, which is 
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proposed to be critical for the set-point of cellular home- 
ostasis, behavioural adaptation and disease susceptibility 
(De Kloet, 1991, JoSls and De Kloet, 1991, 1992; JoSls et 
al., 1991). The hippocampal formation is most likely re- 
quired to process the kinds of complex stimulus represen- 
tations that make up the context. The contextual factors are 
an essential part of what gives a stimulus its meaning 
(LeDoux, 1993, 1995). Accordingly, it has been reported 
that the ability to integrate incoming stimuli was decreased 
in patients lacking cortisol and was normalized by gluco- 
corticoid replacement (Henkin, 1970). Therefore it is sug- 
gested that the changed mineralocorticoid receptor/gluco- 
corticoid receptor balance due to glucocorticoid receptor 
antisense or glucocorticoid receptor antagonist treatment 
leads to an altered interpretation f the given environment, 
i.e., inescapability in the forced swim test. 
In summary, we find that blockade of glucocorticoid 
receptor synthesis in the hippocampal dentate gyrus re- 
duces the time spent on immobility behaviour in the forced 
swim test. Furthermore, the data for glucocorticoid recep- 
tor blockade suggest that the time interval between gluco- 
corticoid receptor blockade and testing is crucial for the 
final behavioural outcome. 
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